JPH0551386A - Spiro pyridopyran compound and guanine indicator using the same - Google Patents
Spiro pyridopyran compound and guanine indicator using the sameInfo
- Publication number
- JPH0551386A JPH0551386A JP3213615A JP21361591A JPH0551386A JP H0551386 A JPH0551386 A JP H0551386A JP 3213615 A JP3213615 A JP 3213615A JP 21361591 A JP21361591 A JP 21361591A JP H0551386 A JPH0551386 A JP H0551386A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- guanine
- group
- formula
- spiropyridopyran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thermal Transfer Or Thermal Recording In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、新規なスピロピリドピ
ラン系化合物及びそれを使用したグアニンインディケー
ターに関するものである。詳しくは、グアニン誘導体に
対し、これを選択的に認識して発色する新規なスピロピ
リドピラン系化合物及びそれを使用したグアニンインデ
ィケーターに関するものである。TECHNICAL FIELD The present invention relates to a novel spiropyridopyran compound and a guanine indicator using the same. More specifically, the present invention relates to a novel spiropyridopyran compound that selectively recognizes a guanine derivative and develops a color, and a guanine indicator using the same.
【0002】[0002]
【従来の技術】従来、グアニン誘導体に対し、これを選
択的に認識して発色する化合物は既に知られており、こ
れらはグアニンインディケーターとして利用されてい
る。2. Description of the Related Art Conventionally, a compound which selectively recognizes a guanine derivative and develops a color has already been known, and these compounds are used as a guanine indicator.
【0003】[0003]
【発明が解決しようとする課題】各種工業分野におい
て、機能性化合物として、従来にない新たな化合物を開
発することは常に望まれている。In various industrial fields, it is always desired to develop new compounds that have never existed as functional compounds.
【0004】本発明は、グアニン誘導体に対し、これを
選択的に認識して発色し得る、グアニンインディケータ
ーとして有効に使用することができる化合物であって、
従来公知の化合物とは異なる化学構造を有する新規なス
ピロピリドピラン系化合物を提供することを目的とす
る。The present invention relates to a guanine derivative, which is a compound which can be effectively used as a guanine indicator capable of selectively recognizing the guanine derivative to develop a color.
It is an object of the present invention to provide a novel spiropyridopyran compound having a chemical structure different from that of conventionally known compounds.
【0005】[0005]
【課題を解決するための手段及び作用】請求項1のスピ
ロピリドピラン系化合物は、下記一般式[I]で表わさ
れるものである。Means and Actions for Solving the Problems The spiropyridopyran compound according to claim 1 is represented by the following general formula [I].
【0006】[0006]
【化2】 [Chemical 2]
【0007】(式中、R1 ,R2 はアルキル基を示し、
R3 は置換基を有していてもよいアルキル基を示し、R
4 は水素原子又はアルキル基、アシル基を示し、=X−
は=CH−又は=N−を示し、Yは酸素原子又はイオウ
原子を示し、環Aは置換されていてもよい炭化水素系芳
香環を示す。)請求項2のグアニンインディケーター
は、請求項1に記載のスピロピリドピラン系化合物を使
用することを特徴とする。(Wherein R 1 and R 2 represent an alkyl group,
R 3 represents an alkyl group which may have a substituent, and R 3
4 represents a hydrogen atom, an alkyl group or an acyl group, and = X-
Represents = CH- or = N-, Y represents an oxygen atom or a sulfur atom, and ring A represents an optionally substituted hydrocarbon aromatic ring. ) The guanine indicator according to claim 2 is characterized by using the spiropyridopyran compound according to claim 1.
【0008】以下、本発明を詳細に説明する。The present invention will be described in detail below.
【0009】前記一般式[I]において、R1 ,R2 で
示されるアルキル基としては、メチル基、エチル基、プ
ロピル基、ブチル基、ペンチル基、ヘプチル基等の炭素
数1〜7のアルキル基が挙げられ、好ましくは、メチル
基、エチル基又はプロピル基が挙げられる。In the general formula [I], the alkyl group represented by R 1 and R 2 is an alkyl group having 1 to 7 carbon atoms such as methyl group, ethyl group, propyl group, butyl group, pentyl group and heptyl group. Group, and preferably a methyl group, an ethyl group or a propyl group.
【0010】R3 で示される置換基を有していてもよい
アルキル基としては、炭素数1〜12のアルキル基、炭
素数1〜10のアルコキシ基で置換された炭素数1〜1
2のアルキル基等のアルコキシアルキル基、炭素数1〜
10のアルキルカルボニルオキシ基、ベンゾイルオキシ
基等のアシルオキシ基で置換された炭素数1〜12のア
ルキル基等のアシルオキシアルキル基、炭素数1〜10
のアルコキシカルボニル基で置換された炭素数1〜12
のアルキル基等のアルコキシカルボニルアルキル基、ア
ルコキシアルコキシアルキル基、下記式等で示される
アラルキル基等が挙げられる。The alkyl group which may have a substituent represented by R 3 is an alkyl group having 1 to 12 carbon atoms, or an alkyl group having 1 to 1 carbon atoms substituted with an alkoxy group having 1 to 10 carbon atoms.
Alkoxyalkyl groups such as alkyl groups of 2, 1 to 1 carbon atoms
An acyloxyalkyl group such as an alkyl group having 1 to 12 carbon atoms substituted with an acyloxy group such as an alkylcarbonyloxy group having 10 carbon atoms or a benzoyloxy group, and having 1 to 10 carbon atoms
1-12 carbon atoms substituted with the alkoxycarbonyl group of
Alkoxycarbonylalkyl groups such as alkyl groups, alkoxyalkoxyalkyl groups, and aralkyl groups represented by the following formulas and the like.
【0011】[0011]
【化3】 [Chemical 3]
【0012】(式中、mは1〜3の整数を示し、R5 は
炭素数1〜10のアルキル基又はアルコキシ基を示
す。)R4 としては、水素原子の他、炭素数1〜10の
アルキル基、炭素数1〜10のアルキルカルボニル基、
ベンゾイル基等のアシル基が挙げられる。(In the formula, m represents an integer of 1 to 3, R 5 represents an alkyl group or an alkoxy group having 1 to 10 carbon atoms.) R 4 has 1 to 10 carbon atoms in addition to a hydrogen atom. Alkyl group, an alkylcarbonyl group having 1 to 10 carbon atoms,
An acyl group such as a benzoyl group can be mentioned.
【0013】環Aの炭化水素系芳香環としては、ベンゼ
ン環、ナフタレン環等が挙げられ、好ましくは、ベンゼ
ン環が挙げられる。環Aの芳香環の置換基としては水素
原子;塩素原子、臭素原子、ヨウ素原子等のハロゲン原
子;ニトロ基;炭素数1〜6のアルキル基等のアルキル
基;炭素数1〜6のアルコキシ基等のアルコキシ基;炭
素数1〜6のアルコキシカルボニル基等のアルコキシカ
ルボニル基;メトキシスルホニル基、エトキシスルホニ
ル基等のアルコキシスルホニル基;メチルスルホニル
基、エチルスルホニル基等のアルキルスルホニル基等が
挙げられる。Examples of the hydrocarbon-based aromatic ring of ring A include a benzene ring and a naphthalene ring, and preferably a benzene ring. As a substituent of the aromatic ring of ring A, a hydrogen atom; a halogen atom such as a chlorine atom, a bromine atom, an iodine atom; a nitro group; an alkyl group such as an alkyl group having 1 to 6 carbon atoms; an alkoxy group having 1 to 6 carbon atoms And the like; alkoxycarbonyl groups such as alkoxycarbonyl groups having 1 to 6 carbon atoms; alkoxysulfonyl groups such as methoxysulfonyl group and ethoxysulfonyl group; and alkylsulfonyl groups such as methylsulfonyl group and ethylsulfonyl group.
【0014】前記一般式[I]で示される本発明のスピ
ロピリドピラン系化合物は、グアニン誘導体により発色
するが、それは下記に示す一般式[II]におけるよう
に、水素結合により、グアニンを選択的に認識する結果
である。The spiropyridopyran compound of the present invention represented by the above general formula [I] develops color by a guanine derivative, which is selected by guanine by hydrogen bond as in the following general formula [II]. This is the result of a positive recognition.
【0015】[0015]
【化4】 [Chemical 4]
【0016】(一般式[II]におけるR1 ,R2 ,R
3 ,R4 ,X,Y及び環Aは一般式[I]におけると同
意義を表わし、Gは下記一般式[III] におけると同意義
を表わす。)なお、上記グアニン誘導体はグアニン基を
含んでいればよく、特に限定されないが、例えば以下の
一般式[III] で表わされるグアニン誘導体が挙げられ
る。(R 1 , R 2 , R in the general formula [II]
3 , R 4 , X, Y and ring A have the same meaning as in general formula [I], and G has the same meaning as in general formula [III] below. The guanine derivative is not particularly limited as long as it contains a guanine group, and examples thereof include a guanine derivative represented by the following general formula [III].
【0017】[0017]
【化5】 [Chemical 5]
【0018】(式中、Gは水素原子又は下記式で表わ
される基を示す。)(In the formula, G represents a hydrogen atom or a group represented by the following formula.)
【0019】[0019]
【化6】 [Chemical 6]
【0020】(式中、R6 は水素原子又は−OSiMe
2 Bu(t)を示す。なお、Meはメチル基、Buはブ
チル基である。)前記一般式[I]で表わされる本発明
のスピロピリドピラン系化合物は、例えば、次のように
して製造することができる。即ち、下記一般式[IV]で
表わされる化合物と、下記一般式[V]で表わされる化
合物とを反応させることにより合成することができる。(In the formula, R 6 is a hydrogen atom or --OSiMe.
2 Indicates Bu (t). In addition, Me is a methyl group and Bu is a butyl group. ) The spiropyridopyran compound of the present invention represented by the above general formula [I] can be produced, for example, as follows. That is, it can be synthesized by reacting a compound represented by the following general formula [IV] with a compound represented by the following general formula [V].
【0021】[0021]
【化7】 [Chemical 7]
【0022】(式中、R1 ,R2 ,R3 及び環Aは、前
記一般式[I]におけると同意義を示し、X- は1価の
陰イオンを示す。X- で示される1価の陰イオンとして
はクロルイオン、ブロムイオン、ヨードイオン等のハロ
ゲンイオン、過塩素酸イオン、四フッ化ほう素酸イオン
等が挙げられる。)(In the formula, R 1 , R 2 , R 3 and ring A have the same meaning as in the above formula [I], and X − represents a monovalent anion. 1 represented by X − Examples of valent anions include halogen ions such as chlorine ion, bromide ion, and iodo ion, perchlorate ion, and tetrafluoroborate ion.)
【0023】[0023]
【化8】 [Chemical 8]
【0024】(式中、X,Y及びR4 は、前記一般式
[I]におけると同意義を示す。)この反応は通常、塩
化メチレン、クロロホルム等のハロゲン化炭化水素、或
いは、メタノール、エタノール、プロパノール、ブタノ
ール等のアルコール系溶媒の存在下で、反応温度−20
〜100℃において実施される。(In the formula, X, Y and R 4 have the same meanings as in the above formula [I].) This reaction is usually a halogenated hydrocarbon such as methylene chloride or chloroform, or methanol or ethanol. At a reaction temperature of -20
It is carried out at -100 ° C.
【0025】このようにして得られる本発明のスピロピ
リドピラン系化合物の具体例を次の表1、表2に示す。Specific examples of the spiropyridopyran compound of the present invention thus obtained are shown in Tables 1 and 2 below.
【0026】[0026]
【表1】 [Table 1]
【0027】[0027]
【表2】 [Table 2]
【0028】このような本発明のスピロピリドピラン系
化合物は、その用途に応じて、例えばバインダーと共に
溶媒に溶解してインク組成物としたり、これを適当な基
材上に塗布乾燥したり、或いは、樹脂中に溶解又は分散
した後成膜するなどして使用することができる。Such a spiropyridopyran compound of the present invention may be dissolved in a solvent together with a binder to form an ink composition, or it may be coated on an appropriate substrate and dried, depending on the application. Alternatively, it can be used by dissolving or dispersing it in a resin and then forming a film.
【0029】なお、本発明化合物を使用したインク組成
物に用いる溶媒としては、本発明化合物を溶解するもの
であればよく、特に限定されない。The solvent used in the ink composition containing the compound of the present invention is not particularly limited as long as it can dissolve the compound of the present invention.
【0030】また、本発明化合物を溶解又は分散する樹
脂としては、ポリエステル樹脂、ポリスチレン樹脂、ポ
リビニルブチラール樹脂、ポリ塩化ビニリデン、ポリ塩
化ビニル、ポリメタクリル酸メチル、ポリ酢酸ビニル、
酢酸セルロース、エポキシ樹脂、フェノール樹脂等が挙
げられる。成膜方法としては種々の公知の方法を採用す
ることができる。As the resin for dissolving or dispersing the compound of the present invention, polyester resin, polystyrene resin, polyvinyl butyral resin, polyvinylidene chloride, polyvinyl chloride, polymethyl methacrylate, polyvinyl acetate,
Cellulose acetate, epoxy resin, phenol resin and the like can be mentioned. As a film forming method, various known methods can be adopted.
【0031】本発明化合物を樹脂中に溶解又は分散して
使用する際、安定性や耐光性を向上させる目的で、酸化
防止剤や一重項酸素クエンチャー等を添加してもよい。When the compound of the present invention is used after being dissolved or dispersed in a resin, an antioxidant and a singlet oxygen quencher may be added for the purpose of improving stability and light resistance.
【0032】本発明のスピロピリドピラン系化合物は、
グアニン誘導体に対し、これを選択的に認識して発色す
ることから、グアニンインディケーターとして有効に使
用することができるが、その他、この発色システムを利
用して、記録材料、記憶材料、示温材料等として使用す
ることもできる。The spiropyridopyran compound of the present invention is
It can be effectively used as a guanine indicator because it selectively recognizes a guanine derivative and develops color. In addition, by using this color development system, recording materials, memory materials, temperature indicating materials, etc. Can also be used as
【0033】[0033]
【実施例】次に、本発明を実施例によって更に具体的に
説明するが、本発明は、その要旨を超えない限り、以下
の実施例に限定されるものではない。EXAMPLES Next, the present invention will be described more specifically by way of examples, but the present invention is not limited to the following examples unless it exceeds the gist thereof.
【0034】実施例1 表1、No.1のスピロピリドピラン系化合物の製造: (1)6−アセチルアミノ−3−シアノ−2−アセチル
オキシピリジンの合成Example 1 Table 1, No. 1 Preparation of Spiropyridopyran Compound of 1: (1) Synthesis of 6-acetylamino-3-cyano-2-acetyloxypyridine
【0035】[0035]
【化9】 [Chemical 9]
【0036】6−アミノ−3−シアノ−2−ヒドロキシ
ピリジン(P. Pojanagaroon, Ph. D. Thesis. Universi
ty of North Carolina, 1969)20mmolを無水酢酸
(Ac2 O)(30ml)に懸濁させ、120℃で12
時間反応させた。反応終了後、無水酢酸を減圧下で除去
し、残渣をシリカゲルカラムクロマトグラフィーを用い
て精製した(展開液;CH2 Cl2 :AcOEt(酢酸
エチル)=20:1)。収率70%。6-amino-3-cyano-2-hydroxypyridine (P. Pojanagaroon, Ph. D. Thesis. Universi
ty of North Carolina, 1969) 20 mmol was suspended in acetic anhydride (Ac 2 O) (30 ml) and the suspension was added at 120 ° C. for 12 hours.
Reacted for hours. After completion of the reaction, acetic anhydride was removed under reduced pressure, and the residue was purified by silica gel column chromatography (developing solution; CH 2 Cl 2 : AcOEt (ethyl acetate) = 20: 1). Yield 70%.
【0037】分析結果 IR(KBr):3250,2230,1790,16
80,1520cm-1 1 H−NMR(270MHz,CDCl3 ):δ 2.
24(s,3H),2.41(s,3H),8.01
(d,J=8.6Hz,1H),8.27(d,J=
8.6Hz,1H)13 C−NMR(67.5MHz,CDCl3 ):δ 2
1.26,25.26,98.10,111.86,1
14.47,145.46,153.45,158.2
4,168.04,169.17 MS(m/z):219(M+ ,6%),177(M+
−COCH3 +H,37%),135(M+ −2COC
H3 +2H,100%) (2)6−アセチルアミノ−3−シアノ−2−ヒドロキ
シピリジンの合成 Analysis result IR (KBr): 3250, 2230, 1790, 16
80,1520cm -1 1 H-NMR (270MHz , CDCl 3): δ 2.
24 (s, 3H), 2.41 (s, 3H), 8.01
(D, J = 8.6 Hz, 1H), 8.27 (d, J =
8.6 Hz, 1 H) 13 C-NMR (67.5 MHz, CDCl 3 ): δ 2
1.26, 25.26, 98.10, 111.86, 1
14.47, 145.46, 153.45, 158.2
4,168.04,169.17 MS (m / z): 219 (M + , 6%), 177 (M +
-COCH 3 + H, 37%) , 135 (M + -2COC
(H 3 + 2H, 100%) (2) Synthesis of 6-acetylamino-3-cyano-2-hydroxypyridine
【0038】[0038]
【化10】 [Chemical 10]
【0039】(1)で得られた6−アセチルアミノ−3
−シアノ−2−アセチルオキシピリジン10mmolを
MeOH:CH2 Cl2 :AcOH:H2 O(20:2
0:1:1(ml))に溶かし、室温で25時間撹拌し
た。生じた沈殿を濾過することにより目的物を得た。収
率94%。6-Acetylamino-3 obtained in (1)
10 mmol of cyano-2-acetyloxypyridine was added to MeOH: CH 2 Cl 2 : AcOH: H 2 O (20: 2
It was dissolved in 0: 1: 1 (ml)) and stirred at room temperature for 25 hours. The target product was obtained by filtering the generated precipitate. Yield 94%.
【0040】分析結果 IR(KBr):3430,3100,2210,15
90,1560cm-1 1 H−NMR(270MHz,DMSO−d6 ):δ
2.15(s,3H),6.89(d,J=8.2H
z,1H),7.84(d,J=8.2Hz,1H),
11.01(s,1H),12.15(s,1H)13 C−NMR(67.5MHz,DMSO−d6 ):δ
24.40,91.17,96.38,118.5
0,147.43,151.89,166.53,17
0.41 MS(m/z):177(M+ ,20%),135(M
+−COCH3 +H,100%) (3)6−アセチルアミノ−3−ホルミル−2−ヒドロ
キシピリジン[Va]の合成 Analysis result IR (KBr): 3430, 3100, 2210, 15
90,1560cm -1 1 H-NMR (270MHz , DMSO-d 6): δ
2.15 (s, 3H), 6.89 (d, J = 8.2H
z, 1H), 7.84 (d, J = 8.2Hz, 1H),
11.01 (s, 1H), 12.15 (s, 1H) 13 C-NMR (67.5 MHz, DMSO-d 6 ): δ
24.40, 91.17, 96.38, 118.5
0, 147.43, 151.89, 166.53, 17
0.41 MS (m / z): 177 (M + , 20%), 135 (M
+ -COCH 3 + H, 100% ) (3) 6- Synthesis of acetyl-amino-3-formyl-2-hydroxypyridine [Va]
【0041】[0041]
【化11】 [Chemical 11]
【0042】(2)で得られた6−アセチルアミノ−3
−シアノ−2−ヒドロキシピリジン(5.0mmol)
及びラネーNi(W−6,1.0g)、ホスフィン酸ナ
トリウム一水和物(1.7g)をH2 O:AcOH:ピ
リジン(6.3:6.3:12.5(ml))に懸濁さ
せ、オートクレーブ中で12気圧の水素圧力下、室温で
24時間撹拌した。反応終了後、反応混合物を濾過し、
濾液を減圧下で処理して溶媒を除去した後、残渣をシリ
カゲルカラムクロマトグラフィーで精製した(展開液;
CH2 Cl2 :EtOH=20:1)。収率73%。6-Acetylamino-3 obtained in (2)
-Cyano-2-hydroxypyridine (5.0 mmol)
And Raney Ni (W-6, 1.0 g) and sodium phosphinate monohydrate (1.7 g) in H 2 O: AcOH: pyridine (6.3: 6.3: 12.5 (ml)). The suspension was suspended and stirred in an autoclave under a hydrogen pressure of 12 atm at room temperature for 24 hours. After the reaction was completed, the reaction mixture was filtered,
The filtrate was treated under reduced pressure to remove the solvent, and the residue was purified by silica gel column chromatography (developing solution;
CH 2 Cl 2 : EtOH = 20: 1). Yield 73%.
【0043】分析結果 IR(KBr):3400,3150,2950,16
90,1570cm-1 1 H−NMR(270MHz,DMSO−d6 ):δ
2.17(s,3H),6.69(d,J=8.2H
z,1H),7.94(d,J=8.2Hz,1H),
9.96(s,1H)13 C−NMR(67.5MHz,DMSO−d6 ):δ
24.48,96.14,116.33,143.6
0,151.95,162.61,172.03,18
7.67 MS(m/z):180(M+ ,25%),138(M
+−COCH3 +H,92%) (4)スピロピリドピラン系化合物[Ia]の合成 Analysis results IR (KBr): 3400, 3150, 2950, 16
90,1570cm -1 1 H-NMR (270MHz , DMSO-d 6): δ
2.17 (s, 3H), 6.69 (d, J = 8.2H
z, 1H), 7.94 (d, J = 8.2Hz, 1H),
9.96 (s, 1H) 13 C-NMR (67.5 MHz, DMSO-d 6 ): δ
24.48, 96.14, 116.33, 143.6
0, 151.95, 162.61, 172.03, 18
7.67 MS (m / z): 180 (M + , 25%), 138 (M
+ -COCH 3 + H, 92% ) (4) Synthesis of Spiro pyrido pyran-based compounds [Ia]
【0044】[0044]
【化12】 [Chemical formula 12]
【0045】(3)で得られた6−アセチルアミノ−3
−ホルミル−2−ヒドロキシピリジン[Va](前記一
般式[V]において、X=CH,Y=O,R4 =COC
H3)1.0mmolと1,2,3,3−テトラメチル
インドレニウムアイオダイド[IVa](前記一般式[I
V]において、環Aはベンゼン環、R1 =R2 =R3=C
H3 ,X- =I- )1.1mmolとを、CH2 Cl2
(7ml)中で12時間、室温で撹拌した。反応終了後
1.0%炭酸カリウム水溶液(50ml)を加え、塩化
メチレンで数回抽出した。抽出液をロータリーエバポレ
ーターを用いて溶媒を除去した後、残渣をシリカゲルカ
ラムクロマトグラフィーで精製した(展開液;ヘキサ
ン:AcOEt:Et3 N=10:10:1)。収率5
7%。6-Acetylamino-3 obtained in (3)
- In-formyl-2-hydroxypyridine [Va] (Formula [V], X = CH, Y = O, R 4 = COC
H 3 ) 1.0 mmol and 1,2,3,3-tetramethylindolenium iodide [IVa] (the above-mentioned general formula [I
V], the ring A is a benzene ring, and R 1 ═R 2 ═R 3 ═C
H 3 , X − = I − ) 1.1 mmol and CH 2 Cl 2
It was stirred in (7 ml) for 12 hours at room temperature. After completion of the reaction, 1.0% aqueous potassium carbonate solution (50 ml) was added, and the mixture was extracted several times with methylene chloride. The solvent was removed from the extract using a rotary evaporator, and the residue was purified by silica gel column chromatography (developing solution; hexane: AcOEt: Et 3 N = 10: 10: 1). Yield 5
7%.
【0046】分析結果 IR(KBr): 3400,3210,1730,1710cm-1 1 H−NMR(CDCl3 ,270MHz):δ 1.
18(s,3H),1.32(s,3H),2.10
(s,3H),2.75(s,3H),5.69(d,
J=10.4Hz,1H),6.51(d,J=7.5
Hz,1H),6.80(t−d,J=7.5,1.2
Hz,1H),6.82(d,J=10.4Hz,1
H),7.04(t−d,J=7.5,1.2Hz,1
H),7.12(t−d,J=7.5,1.2Hz,1
H),7.40(d,J=7.9Hz,1H),7.7
0(d,J=7.9Hz,1H),7.77(br.
s,1H)13 C−NMR(CDCl3 ,67.5MHz):δ 2
0.40,25.07,26.44,29.35,5
2.33,106.65,107.64,108.2
9,110.49,119.51,120.01,12
1.95,128.06,128.40,136.7
1,137.64,148.29,149.85,15
9.83,168.83 MS(m/z):335(M+ ,63%) 実施例2 実施例1で得たスピロピリドピラン系化合物[Ia]の
グアニン誘導体による発色:実施例1で得たスピロピリ
ドピラン系化合物[Ia]2.99×10-5molの塩
化メチレン溶液に、モル比で10倍の下記に示すヌクレ
オシド誘導体[IIIG] ,[IIIC] ,[IIIA] ,[IIIT]
,[IIIU] を加え、その紫外−可視スペクトルを測定
した。その結果を図1に示す。その結果、グアニン基を
有するヌクレオシド誘導体[IIIG] を加えた時のみ、強
く赤色に発色した。これはスピロピリドピラン系化合物
[Ia]がヌクレオシド誘導体[IIIG] のグアニン基を
選択的に認識し、前記一般式[II]のごとく開環した結
果である。The analytical results IR (KBr): 3400,3210,1730,1710cm -1 1 H-NMR (CDCl 3, 270MHz): δ 1.
18 (s, 3H), 1.32 (s, 3H), 2.10
(S, 3H), 2.75 (s, 3H), 5.69 (d,
J = 10.4 Hz, 1H), 6.51 (d, J = 7.5)
Hz, 1H), 6.80 (t-d, J = 7.5, 1.2)
Hz, 1H), 6.82 (d, J = 10.4Hz, 1
H), 7.04 (t-d, J = 7.5, 1.2 Hz, 1
H), 7.12 (t-d, J = 7.5, 1.2 Hz, 1
H), 7.40 (d, J = 7.9 Hz, 1H), 7.7
0 (d, J = 7.9 Hz, 1H), 7.77 (br.
s, 1H) 13 C-NMR (CDCl 3 , 67.5 MHz): δ 2
0.40, 25.07, 26.44, 29.35, 5
2.33, 106.65, 107.64, 108.2
9, 110.49, 119.51, 120.01, 12
1.95, 128.06, 128.40, 136.7
1,137.64, 148.29, 149.85, 15
9.83, 168.83 MS (m / z): 335 (M + , 63%) Example 2 Coloring of spiropyridopyran compound [Ia] obtained in Example 1 by guanine derivative: in Example 1 The spiropyridopyran compound [Ia] 2.99 × 10 −5 mol in methylene chloride solution was added to the following nucleoside derivatives [IIIG], [IIIC], [IIIA], and [IIIT] in a molar ratio of 10 times. ]
, [IIIU] was added and the UV-visible spectrum was measured. The result is shown in FIG. As a result, a strong red color was developed only when the nucleoside derivative [IIIG] having a guanine group was added. This is the result of the spiropyridopyran compound [Ia] selectively recognizing the guanine group of the nucleoside derivative [IIIG] and opening the ring as in the above general formula [II].
【0047】[0047]
【化13】 [Chemical 13]
【0048】[IIIG] :B=グアニン,R=OSiMe
2Bu(t) [IIIC] :B=シトシン,R=OSiMe2 Bu(t) [IIIA] :B=アデニン,R=OSiMe2 Bu(t) [IIIT] :B=チミン,R=H [IIIU] :B=ウラシル,R=OSiMe2 Bu(t) 実施例3 実施例2における発色のシトシン誘導体による発色阻
害:実施例2で調製したスピロピリドピラン系化合物
[Ia]とグアニン誘導体[IIIG] との発色溶液に、グ
アニン誘導体に対してモル比で3倍のヌクレオシド誘導
体[IIIU] ,[IIIT] ,[IIIA] ,[IIIC] を加え、そ
の後、紫外−可視吸収スペクトルを測定した。結果を図
2に示す。[IIIG]: B = guanine, R = OSiMe
2 Bu (t) [IIIC]: B = cytosine, R = OSiMe 2 Bu (t) [IIIA]: B = adenine, R = OSiMe 2 Bu (t) [IIIT]: B = thymine, R = H [IIIU] ]: B = uracil, R = OSiMe 2 Bu (t) Example 3 Inhibition of color development in Example 2 by cytosine derivative: Spiropyridopyran compound [Ia] and guanine derivative [IIIG] prepared in Example 2 The nucleoside derivatives [IIIU], [IIIT], [IIIA], and [IIIC] were added to the color-developing solution with the guanine derivative in a molar ratio of 3 times, and then the UV-visible absorption spectrum was measured. The results are shown in Figure 2.
【0049】図2に示したごとく、ヌクレオシド誘導体
[IIIC] を加えた時にのみ、前記発色(赤色)が阻害さ
れた。これはグアニン基とシトシン基が強くWatso
n−Crick型相補的相互作用し、前記、スピロピリ
ドピラン系化合物[Ia]とグアニン誘導体[IIIG] と
の結合が切断されたためであり、本発明のスピロピリド
ピラン系化合物[Ia]とグアニン誘導体[IIIG] が分
子認識による相互作用をしていたことを示している。As shown in FIG. 2, the nucleoside derivative
The color development (red) was inhibited only when [IIIC] was added. This is because guanine group and cytosine group are strong and Watso
This is because the spiropyridopyran-based compound [Ia] of the present invention and the spiropyridopyran-based compound [Ia] and the guanine derivative [IIIG] are cleaved by the n-Crick type complementary interaction. It shows that the guanine derivative [IIIG] was interacting by molecular recognition.
【0050】[0050]
【発明の効果】以上詳述した通り、本発明のスピロピリ
ドピラン系化合物は新規な物質であって、グアニン誘導
体を選択的に認識して発色することから、グアニンイン
ディケーター等として工業的に極めて有用である。INDUSTRIAL APPLICABILITY As described in detail above, the spiropyridopyran compound of the present invention is a novel substance and selectively recognizes a guanine derivative to develop a color, so that it is industrially used as a guanine indicator or the like. Extremely useful.
【図1】実施例2の結果を示す紫外−可視スペクトル線
図である。FIG. 1 is an ultraviolet-visible spectrum diagram showing the results of Example 2.
【図2】実施例3の結果を示す紫外−可視スペクトル線
図である。FIG. 2 is an ultraviolet-visible spectrum diagram showing the results of Example 3.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C07D 513/20 8415−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location C07D 513/20 8415-4C
Claims (2)
リドピラン系化合物。 【化1】 (式中、R1 ,R2 はアルキル基を示し、R3 は置換基
を有していてもよいアルキル基を示し、R4 は水素原子
又はアルキル基、アシル基を示し、=X−は=CH−又
は=N−を示し、Yは酸素原子又はイオウ原子を示し、
環Aは置換されていてもよい炭化水素系芳香環を示
す。)1. A spiropyridopyran compound represented by the following general formula [I]: [Chemical 1] (In the formula, R 1 and R 2 represent an alkyl group, R 3 represents an alkyl group which may have a substituent, R 4 represents a hydrogen atom, an alkyl group or an acyl group, and = X- represents ═CH— or ═N—, Y represents an oxygen atom or a sulfur atom,
Ring A represents an optionally substituted hydrocarbon aromatic ring. )
化合物を使用することを特徴とするグアニンインディケ
ーター。2. A guanine indicator characterized by using the spiropyridopyran compound according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3213615A JP3055234B2 (en) | 1991-08-26 | 1991-08-26 | Spiropyridopyrane compound and guanine indicator using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3213615A JP3055234B2 (en) | 1991-08-26 | 1991-08-26 | Spiropyridopyrane compound and guanine indicator using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0551386A true JPH0551386A (en) | 1993-03-02 |
JP3055234B2 JP3055234B2 (en) | 2000-06-26 |
Family
ID=16642112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3213615A Expired - Fee Related JP3055234B2 (en) | 1991-08-26 | 1991-08-26 | Spiropyridopyrane compound and guanine indicator using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3055234B2 (en) |
-
1991
- 1991-08-26 JP JP3213615A patent/JP3055234B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3055234B2 (en) | 2000-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4169204A (en) | Psoralens | |
US3850941A (en) | 2-alkyl-3-acylpyrazolo(1,5-a)pyridines | |
JPS6212795A (en) | Novel psolarene derivative | |
EA016552B1 (en) | Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics | |
US4658023A (en) | Porphyrin derivatives | |
JP3839813B2 (en) | Compounds useful for the preparation of camptothecin derivatives | |
JPH0381276A (en) | 5-deazaflavin-based compound and carcinostatic agent comprising same compound as active ingredient | |
JP3037991B2 (en) | New aconitine compounds and analgesic / anti-inflammatory agents | |
JP3055234B2 (en) | Spiropyridopyrane compound and guanine indicator using the same | |
CN101863766A (en) | Beta-hydroxyisovalerylshikonin derivative and preparation method thereof | |
CN112480129B (en) | Polycyclic spiroindoline compound containing guanidyl structural unit and preparation method and application thereof | |
JP2638253B2 (en) | Vitamin D quantification reagent and method for producing the same | |
JPH0269476A (en) | Production of pyrimidine derivative | |
JPS6183163A (en) | Antitumoral | |
JP2917471B2 (en) | Porphyrin derivative | |
JPS61152676A (en) | Production of dibenzo(b,e)oxepine derivative | |
JPH01249792A (en) | Novel oxetane derivative and preparation thereof | |
JPH02124897A (en) | Production of erythrofuranosil nucleoside derivative and novel derivative | |
JPH0216311B2 (en) | ||
JPH0331257A (en) | Production of indole derivative | |
JPS63301885A (en) | Production of spirooxazine compound | |
JP3804208B2 (en) | Method for producing azulene derivatives | |
JPH01294661A (en) | Production of 4-acetoxyazetidinone derivative | |
Young | Thermal and photochemical cycloaromatization reactions of ortho-dialkynylarenes: A new class of DNA photocleaving agents | |
JPS5916879A (en) | Production of n-substituted imidazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090414 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090414 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100414 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |